[{"NetIncomeLoss_2_Q2_USD":2868500000.0,"LiabilitiesNoncurrent_0_Q2_USD":25706500000.0,"OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_2_Q2_USD":-328700000.0,"OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_1_Q2_USD":114100000.0,"CommitmentsAndContingencies_0_Q2_USD":null,"PaymentsToAcquireLongtermInvestments_2_Q2_USD":154800000.0,"RepaymentsOfLongTermDebt_2_Q2_USD":276300000.0,"PaymentsToAcquireShortTermInvestments_2_Q2_USD":0.0,"CommonStockDividendsPerShareDeclared_1_Q2_USD":0.74,"EquitySecuritiesFvNiGainLoss_1_Q2_USD":577500000.0,"EquitySecuritiesFvNiGainLoss_2_Q2_USD":742200000.0,"DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear_0_Q2_USD":10000000.0,"TranslationAdjustmentForNetInvestmentHedgeNetOfTax_0_Q2_USD":4100000000.0,"IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_1_Q2_USD":0.0,"IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_2_Q2_USD":0.0,"CommonStockDividendsPerShareDeclared_2_Q2_USD":0.74,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q2_USD":-6682900000.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":-1271300000.0,"ProceedsFromSaleOfShortTermInvestments_2_Q2_USD":111200000.0,"TreasuryStockValue_0_Q2_USD":55700000.0,"CostOfGoodsAndServicesSold_2_Q2_USD":2437100000.0,"CostOfGoodsAndServicesSold_1_Q2_USD":1222000000.0,"ProceedsFromIssuanceOfLongTermDebt_2_Q2_USD":988600000.0,"ContractWithCustomerLiability_0_Q2_USD":299800000.0,"SellingGeneralAndAdministrativeExpense_2_Q2_USD":2998200000.0,"SellingGeneralAndAdministrativeExpense_1_Q2_USD":1448600000.0,"ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_1_Q2_USD":-88900000.0,"ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_2_Q2_USD":-169400000.0,"RestructuringSettlementAndImpairmentProvisions_1_Q2_USD":0.0,"RestructuringSettlementAndImpairmentProvisions_2_Q2_USD":59900000.0,"AssetsCurrent_0_Q2_USD":14581900000.0,"PaymentsForProceedsFromOtherInvestingActivities_2_Q2_USD":-4100000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_Q2_USD":1200000.0,"StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_0_Q2_USD":1000000000.0,"IncreaseDecreaseInOtherOperatingCapitalNet_2_Q2_USD":481600000.0,"AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue_0_Q2_USD":131400000.0,"InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet_0_Q2_USD":-16500000.0,"GainLossOnInvestments_2_Q2_USD":765000000.0,"IncomeTaxExpenseBenefit_2_Q2_USD":455100000.0,"AccountsReceivableNetCurrent_0_Q2_USD":4828900000.0,"OtherNonoperatingIncomeExpense_1_Q2_USD":492200000.0,"OtherNonoperatingIncomeExpense_2_Q2_USD":614900000.0,"PrepaidExpenseCurrent_0_Q2_USD":3104500000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":910900000.0,"IncomeTaxExpenseBenefit_1_Q2_USD":231700000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":911600000.0,"IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_1_Q2_USD":1412000000.0,"IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_2_Q2_USD":2868500000.0,"MinorityInterest_0_Q2_USD":179100000.0,"EarningsPerShareBasic_1_Q2_USD":1.56,"EarningsPerShareBasic_2_Q2_USD":3.16,"ResearchAndDevelopmentExpense_2_Q2_USD":2782300000.0,"EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2_Q2_USD":-12400000.0,"AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue_0_Q2_USD":90500000.0,"CommonStockValue_0_Q2_USD":598100000.0,"Revenues_1_Q2_USD":5499400000.0,"AdditionalPaidInCapitalCommonStock_0_Q2_USD":6629400000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":2365100000.0,"IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare_1_Q2_USD":0.0,"IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare_2_Q2_USD":0.0,"OtherAssetsNoncurrent_0_Q2_USD":3080100000.0,"ComprehensiveIncomeNetOfTax_1_Q2_USD":1615000000.0,"ComprehensiveIncomeNetOfTax_2_Q2_USD":2709200000.0,"GainLossOnSaleOfBusiness_2_Q2_USD":0.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":-1566500000.0,"EffectiveIncomeTaxRateContinuingOperations_1_Q2_pure":0.141,"EffectiveIncomeTaxRateContinuingOperations_2_Q2_pure":0.137,"DepreciationDepletionAndAmortization_2_Q2_USD":598000000.0,"AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_0_Q2_USD":115500000.0,"OtherReceivablesNetCurrent_0_Q2_USD":946700000.0,"Revenues_2_Q2_USD":11359200000.0,"PensionContributions_2_Q2_USD":15000000.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q2_USD":357600000.0,"Assets_0_Q2_USD":41967000000.0,"OtherComprehensiveIncomeLossNetOfTax_2_Q2_USD":-159300000.0,"NonoperatingIncomeExpense_2_Q2_USD":536000000.0,"AccountsPayableCurrent_0_Q2_USD":1247200000.0,"LiabilitiesCurrent_0_Q2_USD":11988500000.0,"RepaymentsOfShortTermDebt_2_Q2_USD":235400000.0,"AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_0_Q2_USD":20200000.0,"PaymentsToAcquireProductiveAssets_2_Q2_USD":540100000.0,"NonoperatingIncomeExpense_1_Q2_USD":446900000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":907200000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":2877800000.0,"IncomeLossFromDiscontinuedOperationsNetOfTax_1_Q2_USD":0.0,"IncomeLossFromDiscontinuedOperationsNetOfTax_2_Q2_USD":0.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q2_USD":1643700000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2_Q2_USD":3323600000.0,"Goodwill_0_Q2_USD":3723200000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":907700000.0,"InterestExpense_2_Q2_USD":180800000.0,"InterestExpense_1_Q2_USD":88300000.0,"SeveranceCosts1_2_Q2_USD":9800000.0,"NetIncomeLoss_1_Q2_USD":1412000000.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":7981100000.0,"PaymentsOfDividends_2_Q2_USD":1345500000.0,"ProceedsFromPaymentsForOtherFinancingActivities_2_Q2_USD":-197900000.0,"DeferredIncomeTaxLiabilitiesNet_0_Q2_USD":2039200000.0,"DebtSecuritiesAvailableForSaleUnrealizedLossPosition_0_Q2_USD":18400000.0,"StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0_Q2_USD":4272000000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_0_Q2_USD":2365100000.0,"IncreaseDecreaseInDeferredIncomeTaxes_2_Q2_USD":93500000.0,"IncomeLossFromContinuingOperationsPerDilutedShare_1_Q2_USD":1.55,"IncomeLossFromContinuingOperationsPerDilutedShare_2_Q2_USD":3.15,"IntangibleAssetsNetExcludingGoodwill_0_Q2_USD":7712500000.0,"CommonStockSharesHeldInEmployeeTrust_0_Q2_USD":3013200000.0,"LongTermDebtNoncurrent_0_Q2_USD":15064400000.0,"SeveranceCosts1_1_Q2_USD":0.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q2_USD":20400000.0,"OtherOperatingActivitiesCashFlowStatement_2_Q2_USD":308700000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q2_USD":9297000000.0,"ProceedsFromSaleOfLongtermInvestments_2_Q2_USD":412000000.0,"InvestmentIncomeInterest_1_Q2_USD":7100000.0,"InvestmentIncomeInterest_2_Q2_USD":21400000.0,"InventoryNet_0_Q2_USD":3313900000.0,"PaymentsForRepurchaseOfCommonStock_2_Q2_USD":500000000.0,"AvailableforsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureOtherPercentageOfNonperformingAssets_2_Q2_pure":0.86,"OtherComprehensiveIncomeLossTax_1_Q2_USD":3600000.0,"OtherComprehensiveIncomeLossTax_2_Q2_USD":-23500000.0,"PaymentsToAcquireBusinessesNetOfCashAcquired_2_Q2_USD":849300000.0,"AccruedIncomeTaxesNoncurrent_0_Q2_USD":3377500000.0,"NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent_1_Q2_USD":-35900000.0,"NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent_2_Q2_USD":-80500000.0,"DeferredIncomeTaxAssetsNet_0_Q2_USD":2481800000.0,"TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized_0_Q2_USD":738900000.0,"ShareBasedCompensation_2_Q2_USD":148600000.0,"OtherComprehensiveIncomeLossNetOfTax_1_Q2_USD":203000000.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":41967000000.0,"ResearchAndDevelopmentExpense_1_Q2_USD":1390200000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q2_USD":673600000.0,"OtherLiabilitiesCurrent_0_Q2_USD":2060900000.0,"EarningsPerShareDiluted_1_Q2_USD":1.55,"EarningsPerShareDiluted_2_Q2_USD":3.15,"AssetImpairmentCharges_1_Q2_USD":0.0,"AssetImpairmentCharges_2_Q2_USD":50100000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":27600000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":6617200000.0,"IncomeLossFromContinuingOperationsPerBasicShare_1_Q2_USD":1.56,"IncomeLossFromContinuingOperationsPerBasicShare_2_Q2_USD":3.16,"DebtCurrent_0_Q2_USD":1263800000.0,"TaxesPayableCurrent_0_Q2_USD":1460800000.0,"PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_0_Q2_USD":3398600000.0,"LongTermInvestments_0_Q2_USD":2406400000.0,"AllowanceForDoubtfulAccountsReceivableCurrent_0_Q2_USD":26600000.0,"StockholdersEquity_0_Q2_USD":4092900000.0,"DividendsPayableCurrent_0_Q2_USD":0.0,"OtherLiabilitiesNoncurrent_0_Q2_USD":1826800000.0,"ShortTermInvestments_0_Q2_USD":22800000.0,"Ticker":"LLY","CIK":"59478","name":"ELI LILLY & CO","OfficialName":"Eli Lilly and Company Common Stock","form":"10-Q","period":"20200630","fy":"2020.0","fp":"Q2","qtrs":"2","uom":"USD","footnote":"nan","Market Cap":"282856619893.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NYSE","SP500":"SP500","filed":"20200731"}]